XML 39 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements Of Comprehensive Loss
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
CNY (¥)
¥ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2023
CNY (¥)
¥ / shares
shares
Dec. 31, 2022
CNY (¥)
¥ / shares
shares
Revenues:        
Revenues ¥ 515,822 $ 70,667 ¥ 537,435 ¥ 563,238
Cost of revenues:        
Cost of revenues: (153,422) (21,020) (174,208) (183,199)
Gross Profit 362,400 49,647 363,227 380,039
Operating expenses:        
Research and development expenses (232,290) (31,824) (347,016) (421,868)
Selling and marketing expenses (including related party amounts of RMB201, nil and nil for the years ended December 31, 2022, 2023 and 2024, respectively) (190,904) (26,154) (247,711) (370,294)
General and administrative expenses (261,638) (35,844) (437,821) (568,284)
Impairment loss on long-lived assets (35,127) (4,812) 0 0
Total operating expenses (719,959) (98,634) (1,032,548) (1,360,446)
Loss from operations (357,559) (48,987) (669,321) (980,407)
Interest income 12,212 1,673 17,956 9,356
Interest expense 0 0 0 102
Other income, net 4,706 645 484 152
Foreign exchange gain (loss), net (100) (14) (420) 1,549
Loss before income tax (340,741) (46,683) (651,301) (969,248)
Income tax expenses (5,885) (806) (2,388) (1,985)
Net loss (346,626) (47,489) (653,689) (971,233)
Net loss attributable to Burning Rock Biotech Limited (346,626) (47,489) (653,689) (971,233)
Other comprehensive (loss) income, net of tax of nil:        
Foreign currency translation adjustments 3,485 477 4,189 41,347
Total comprehensive loss (343,141) (47,012) (649,500) (929,886)
Total comprehensive loss attributable to Burning Rock Biotech Limited ¥ (343,141) $ (47,012) ¥ (649,500) ¥ (929,886)
Common Class A [Member]        
Loss per share for class A and class B ordinary shares:        
Loss per share - basic | (per share) ¥ (3.37) $ (0.46) ¥ (6.38) ¥ (9.35)
Loss per share - diluted | (per share) ¥ (3.37) $ (0.46) ¥ (6.38) ¥ (9.35)
Weighted average shares outstanding used in loss per share computation:        
Weighted average shares outstanding used in loss per share - basic 85,610,197 85,610,197 85,071,691 86,584,100
Weighted-average number of ordinary shares outstanding – diluted 85,610,197 85,610,197 85,071,691 86,584,100
Common Class B [Member]        
Loss per share for class A and class B ordinary shares:        
Loss per share - basic | (per share) ¥ (3.37) $ (0.46) ¥ (6.38) ¥ (9.35)
Loss per share - diluted | (per share) ¥ (3.37) $ (0.46) ¥ (6.38) ¥ (9.35)
Weighted average shares outstanding used in loss per share computation:        
Weighted average shares outstanding used in loss per share - basic 17,324,848 17,324,848 17,324,848 17,324,848
Weighted-average number of ordinary shares outstanding – diluted 17,324,848 17,324,848 17,324,848 17,324,848
Service [Member]        
Revenues:        
Revenues ¥ 290,738 $ 39,831 ¥ 345,030 ¥ 391,548
Cost of revenues:        
Cost of revenues: (88,323) (12,100) (101,638) (119,903)
Product [Member]        
Revenues:        
Revenues 225,084 30,836 192,405 171,690
Cost of revenues:        
Cost of revenues: ¥ (65,099) $ (8,920) ¥ (72,570) ¥ (63,296)